HP 293 (Lithium Carbonate Extended-Release 300 mg)
Pill with imprint HP 293 is Beige, Round and has been identified as Lithium Carbonate Extended-Release 300 mg. It is supplied by Heritage Pharmaceuticals Inc..
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; schizoaffective disorder; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HP 293
Lithium Carbonate Extended-Release
- Imprint:
- HP 293
- Strength:
- 300 mg
- Color:
- Beige
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Heritage Pharmaceuticals Inc.
- National Drug Code (NDC):
- 23155-0293
More about lithium
- Lithium Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 280 Reviews
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Lithium
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Capsules and Tablets
- Lithium Syrup and Oral Solution
- Lithium (Advanced Reading)
Other brands: Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
